“I am excited to join AVAVA’s Board of Directors and work with a team committed to advancing the next generation of ...

Cette étude, certes soutenue par le « National Pork Board » américain, et menée par des nutritionnistes de l'Université ...

King Faisal Specialist Hospital & Research Centre (KFSHRC) has solidified its position as a regional leader in advanced ...

Harold’s financial expertise and leadership in scaling up high-growth, healthcare companies are an invaluable addition to ...

SAN FRANCISCO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

RIYADH, Saudi Arabia, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Saudi hospitals have made significant strides in the 2025 Brand Finance global ranking of the world’s Top 250 hospitals, with seven Saudi ...

CAMBRIDGE, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...

IXIARO ® is the only JE vaccine approved by the U.S. Food and Drug Administration (FDA), having been developed through a cooperative research and development agreement with the Walter Reed Army ...

ATLANTA, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of ...

Orion Corporation (“Orion”) and Invenra Inc. (“Invenra”), an innovative biotechnology company with proprietary technologies for discovering novel therapeutics, today announced that they have entered ...